Selank record · updated 17h ago
Selank is a synthetic peptide derived from the naturally occurring peptide tuftsin, primarily studied for its potential anxiolytic and cognitive-enhancing properties. Research into Selank has focused on its effects on neuroprotection, stress response, and cognitive function, although further studies are needed to fully understand its mechanisms and therapeutic applications.
How it works: Anxiolytic heptapeptide (Tuftsin analog)
Development stage
where Selank sits between preclinical work and regulatory approval- 1CurrentPreclinicalAnimal / in-vitro work
- 2Not reachedPhase 1Safety in humans
- 3Not reachedPhase 2Efficacy signal
- 4Not reachedPhase 3Confirmatory trials
- 5Not reachedApprovedCleared by a regulator
Stage is inferred from the highest trial phase in the indexed corpus and 91 registered trials. It describes the research record, not a recommendation.
Mass and formula from PubChem CID 11765600. The chain length is only shown where the residues account for that mass, so a figure here has been checked against it rather than taken on trust.
What people are saying
anecdotal · not evidenceUnverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching Selank will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.